Vesna Skul
Internal Medicine · Chicago, ILNPI 1134223852
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 33.1% of the total. Reporting peaked in 2020 at $498 and has fallen 76.6% since, to $116 in 2025.
Across 97 payments — averaging $24.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$786
- Lilly USA, LLC$300
- Amgen$180
- Medtronic$158
- Teva Pharmaceuticals USA, Inc.$152
- Arbor Pharmaceuticals, Inc.$147
- plus $650 from 14 others
What the payments were for
- Food & beverage$2,26295%
- Education$1115%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $786 |
| Lilly USA, LLC | 16 | $300 |
| Amgen | 11 | $180 |
| Medtronic | 1 | $158 |
| Teva Pharmaceuticals USA, Inc. | 4 | $152 |
| Arbor Pharmaceuticals, Inc. | 8 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $141 |
| Radius Health, Inc. | 2 | $140 |
| Novo Nordisk | 2 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $47 |
| Dynavax Technologies Corporation | 2 | $40 |
| Azurity Pharmaceuticals, Inc. | 2 | $40 |
| Alfasigma USA, Inc. | 2 | $39 |
| Therapeuticsmd, Inc. | 2 | $37 |
| Pfizer | 2 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Exact Sciences | 1 | $18 |
| Shield Therapeutics Inc | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,373 in reported general payments places this provider in the 85th percentile of 5,182 internal medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Liothyronine Sodium | 14 | $1,047 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 12 | $558 |
| Levothyroxine Sodium | 27 | $525 |
| Gabapentin | 18 | $352 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $240 |
| Atorvastatin Calcium | 28 | $227 |
| Allopurinol | 12 | $205 |
| Hydrochlorothiazide | 13 | $201 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Chicago
- Merle DiamondChicago$1.1M
- Robert KushnerChicago$516K
- Romeo UrsuaChicago$420K
- Peter O DonnellChicago$318K
- George UrbanChicago$258K
- Kristen PallokChicago$256K
- George NissanChicago$252K
- Luke LaffinChicago$162K
- Daniel CatenacciChicago$161K
- Hiren ShahChicago$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.